Cargando…
Safety and tolerability of inhalational anticholinergics in COPD
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality. With the significant toll of the disease, more resources have been invested in developing new treatment modalities. Among these medications, inhalational anticholinergics are widely used for the management of...
Autores principales: | Sharafkhaneh, Amir, Majid, Hashir, Gross, Nicholas J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596125/ https://www.ncbi.nlm.nih.gov/pubmed/23526112 http://dx.doi.org/10.2147/DHPS.S7771 |
Ejemplares similares
-
A systematic review of the cardiovascular risk of inhaled anticholinergics in patients with COPD
por: Hilleman, Daniel E, et al.
Publicado: (2009) -
The development of anticholinergics in the management of COPD
por: Scullion, Jane E
Publicado: (2007) -
The mode of action of anticholinergics in asthma
por: Gosens, Reinoud, et al.
Publicado: (2018) -
Bronchodilators in COPD: Impact of β-agonists and anticholinergics on severe exacerbations and mortality
por: Salpeter, Shelley R
Publicado: (2007) -
Clinical efficacy and safety of anticholinergic therapies in pediatric patients
por: Goldstein, Stanley
Publicado: (2019)